Jonathan Waks, MD
Clinical Cardiac Electrophysiology · Boston, MANPI 1467611640
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $105,663 of the $108,341 with a category attached, or 97.5%. Biosense Webster, Inc. accounts for 98.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $99,695 and has fallen 98.0% since, to $1,971 in 2025.
Across 51 payments — averaging $2124.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$106K
- Boston Scientific$2K
- Medtronic$330
- Abbott$14
Across 311 payments — averaging $902.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$217K
- Boston Scientific$63K
What the payments were for
- Consulting fees$105,66398%
- Speaking & faculty fees$1,0001%
- Travel & lodging$440%
- Food & beverage$1,6342%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 42 | $106,201 |
| Boston Scientific | 6 | $1,797 |
| Medtronic(2 entities) | 2 | $330 |
| Abbott | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SmartAblateTM System RF Generator$99,695
- GENERAL - THERAPIES$1,578
- QDOT MICRO Catheter$224
- Micra$168
- CoreValve Evolut$162
- NUVISION ICE CATHETER$117
How this compares
$108,341 in reported general payments places this provider in the 85th percentile of 106 clinical cardiac electrophysiology providers in Massachusetts.
See all clinical cardiac electrophysiology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 116 | $169,934 |
| XareltoRivaroxaban | 54 | $72,362 |
| Metoprolol Succinate | 123 | $2,198 |
| Flecainide Acetate | 29 | $1,525 |
| Amiodarone Hcl | 21 | $459 |
| Atorvastatin Calcium | 15 | $104 |
| Metoprolol Tartrate | 13 | $81 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Boston
- Elad AnterBoston$3.9M
- Jagmeet SinghBoston$619K
- Andre DavilaBoston$379K
- Daniel KramerBoston$247K
- Gregory MichaudBoston$244K
- Laurence EpsteinBoston$172K
- Leon PtaszekBoston$168K
- Moussa MansourBoston$145K
- Andrew LockeBoston$145K
- Peter ZimetbaumBoston$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.